European hunter-gatherers boated to North Africa during Stone Age, ancient DNA suggests
When you buy through links on our articles, Future and its syndication partners may earn a commission.
Ancient hunter-gatherers from Europe may have voyaged across the Mediterranean to Northern Africa around 8,500 years ago, new research suggests.
Ancient DNA collected from the remains of Stone Age individuals from the eastern Maghreb region, which spans Tunisia and northeastern Algeria, revealed that they may have descended, in part, from European hunter-gatherers, according to a paper published March 12 in the journal Nature.
The remains of one of the ancient humans found at a Tunisia site named Djebba was found to have about 6% of his DNA originating from European hunter-gatherer ancestry. These results represent the first clear genetic evidence of contact between early European and North African populations, indicating that Stone Age European hunter-gatherers and North Africans may have interacted more than we initially thought.
"Several decades ago, some biological anthropologists proposed that European and North African hunter-gatherers had made contact, based on morphological analyses of skeletal traits," study co-author Ron Pinhasi, an evolutionary anthropologist at the University of Vienna, said in a statement.
"At the time, this theory appeared overly speculative," he added. "However, 30 years later, our new genomic data has validated these early hypotheses. This is really exciting."
Related: 7,000-year-old canoes from Italy are the oldest ever found in the Mediterranean
The Stone Age began with the use of stone tools about 3 million years ago (before modern humans existed) and ended about 5,000 years ago in parts of North Africa and Europe with the rise of metal tools and early civilizations. During the Stone Age, humans in Europe and North Africa mostly lived as hunter-gatherers, gradually transitioning to farming and more complex societies during the Neolithic, or New Stone Age, which occurred between roughly 10,000 and 2,000 B.C.
Image 1 of 3
A map of the eastern Maghreb in North Africa, including (1) Afalou Bou Rhummel; (2) Djebba; (3) Doukanet el Khoutifa; and (4) Hergla.
Image 2 of 3
The eastern Maghreb archaeological dig site at Doukanet el Khoutifa, Tunisia.
Image 3 of 3
The archaeological site at Hergla, Tunisia
Before now, archaeologists didn't know much about the transition to farming in North Africa, with most genomic data coming from sites in the far western Maghreb (modern-day Morocco).
"There's not been much of a North African story," study co-author David Reich, a population geneticist at Harvard Medical School, told Nature News. "It was a huge hole."
Previous research in the western Maghreb found that people in this area had high levels of European farmer ancestry — genetically distinct from hunter-gatherers — reaching up to 80% in some populations due to the movement of farmers via the Gibraltar Strait around 7,000 years ago.
Image 1 of 2
A researcher excavates human remains at Doukanet el Khoutifa, Tunisia
Image 2 of 2
Scientists process samples from the North African archaeological sites at Harvard Medical School.
The new study reveals that the eastern Maghreb people had comparatively little European farmer ancestry, instead remaining quite genetically isolated — with the surprising exception of some earlier European hunter-gatherer influences.
The archaeologists analyzed the DNA from bones and teeth of nine people who lived between 6,000 and 10,000 years ago in the eastern Maghreb. The DNA showed that one of the ancient humans, who lived about 8,500 years ago, shared about 6% of his DNA with European hunter-gatherers. This suggests that the hunter-gatherers may have boated across the Mediterranean, possibly aboard long wooden canoes.
RELATED STORIES
—Who were the first farmers?
—7 extraordinary African kingdoms from ancient times to centuries ago
—Why did Europe's hunter-gatherers disappear?
Traces of volcanic glass or obsidian from Pantelleria, an island in the Strait of Sicily, was also found at one of the sites, indicating that these hunter-gatherers may have stopped off at several islands on their journey across the sea.
This DNA also revealed that there was very little European farmer ancestry in this region, only reaching around 20%. This suggests that the eastern Maghreb was very genetically and culturally resilient compared to the western Maghreb, which is supported by previous archaeological discoveries that farming was only fully adopted in the eastern Maghreb after about 1000 B.C.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
See the moon shine with famous red star Antares in the southern sky on June 9
When you buy through links on our articles, Future and its syndication partners may earn a commission. The waxing gibbous moon will shine close to the red star Antares in the constellation Scorpius on the night of June 9. Stargazers in the U.S. will find the moon rising higher over the southeastern horizon after sunset on June 9, with Antares shining brightly around 4 degrees to the lower left of the lunar disk. For context, your little finger held at arms length accounts for roughly 1 degree in the night sky, while your index, middle and ring fingers together amount to around 5 degrees, according to NASA. Antares is also known as the "Heart of the Scorpion" thanks to its prominent position in the zodiacal constellation Scorpius, which itself contains a number of stunning deep sky objects, such as the Messier 4 globular cluster and the closest stellar nursery to Earth — Rho Ophiuchi. As a red supergiant, Antares boasts a diameter 700 times greater than our sun and is known to shine roughly 10,000 times brighter. It is expected to end its life in a dramatic supernova explosion when it runs out of fuel — an event that could happen anytime from tomorrow to a million years or so from now. The lunar disk will appear to close in on Antares as the night of June 9 progresses, with the red star eventually setting above the moon's upper left shoulder as the duo slip beneath the southwestern horizon in the predawn hours of June 10. Viewers based in a number of southern hemisphere countries, including Australia, Tasmania and Papua New Guinea, will see the moon slide directly in front of Antares, blocking its light in an event known as an '"occultation" starting at 4:47 a.m. EDT (0847 GMT), according to Stargazers hoping to capture the majesty of the lunar surface should check out our handy guide detailing how to photograph the moon, while those looking for a closer view of the cosmos should read our lists of the best telescopes and binoculars for exploring the night sky. Editor's Note: If you happen to capture a picture of the moon and Antares and want to share it with readers, then please send your photo(s), comments, and your name and location to spacephotos@
Yahoo
2 hours ago
- Yahoo
HIV/AIDS: Facts about the viral infection that attacks the immune system
When you buy through links on our articles, Future and its syndication partners may earn a commission. QUICK FACTS ABOUT HIV What it is: A lifelong viral infection that weakens the immune system, if left untreated Prevention methods: Taking preventive medicines called PrEP, using condoms, and avoiding needle sharing Treatments: Medicines called antiretroviral therapy (ART) Human immunodeficiency virus (HIV) is a germ that causes a lifelong infection that slowly weakens the immune system. Though the infection is lifelong, medicines can keep the virus in check and help people reach lifespans of near-normal length. However, when people don't have access to those medicines, HIV infections progress to an advanced stage called acquired immunodeficiency syndrome (AIDS), which is fatal within about three years if not treated. When a person has AIDS, most of their key, disease-fighting immune cells are lost. This loss of immune protection leaves the person vulnerable to deadly infections and cancers. Although an HIV diagnosis was once a death sentence, scientists have developed treatments that suppress the virus and enable people to live long lives without transmitting the disease to others. Additionally, there are now effective preventive medications that can dramatically reduce the risk of getting HIV in the first place. There is not yet a widespread cure for HIV/AIDS, although a handful of people have been cured of the infection or are in long-term remission thanks to special stem-cell transplants, specially cell transplants from people who have genes that make them resistant to the virus. Scientists are exploring potential avenues for a cure, which could someday mean that people who contract HIV could be rid of the infection rather than having to take medication for life to manage the disease. HIV/AIDS remains a major public health threat worldwide, with an estimated 39.9 million people living with the disease at the end of 2023. Around 630,000 people died from illnesses related to AIDS the same year; by weakening the immune system, AIDS opens the door to these fatal diseases. HIV can spread through contact with an infected person's bodily fluids, although it's important to note that not all bodily fluids can transmit the virus. Bodily fluids that can spread HIV include blood, semen, preseminal fluid, vaginal secretions, breastmilk and rectal discharge (liquid from the anus that's not blood or stool). HIV is not transmitted through saliva, sweat or tears. It's also not spread through the air or through casual contact, such as hugging, shaking hands or sharing food. For transmission to occur, the bodily fluids containing HIV must come into contact with mucous membranes — tissues that line cavities in the body, like the vagina, anus or mouth. The fluids can also transmit HIV when they come into contact with cuts or sores, or when they're introduced to the bloodstream via contaminated needles, for instance. Most people who contract HIV get it through unprotected anal or vaginal sex — meaning sex without a condom or without HIV-preventing medications. People can also contract the virus by sharing the equipment used to inject drugs, such as needles or syringes. Babies can get HIV in the womb, during childbirth or from breastfeeding, if their mother has HIV. People living with HIV who take medicines called ART can suppress the virus to the point that it can't spread via sex. These "virally suppressed" people also have a much lower chance of transmitting HIV to their kids via pregnancy, childbirth or breastfeeding. They are also less likely to spread the virus via shared injection equipment, although experts aren't sure exactly how much the risk is reduced. The symptoms of HIV vary depending on how far the disease has progressed. The virus can spread from one person to another at any stage of the infection, unless the infected person is taking ART and has reached "viral suppression" (see glossary). The initial stage is called "acute HIV infection." Within two to four weeks of contracting the virus, many people develop a flu-like illness involving symptoms like fever, headache, rash and sore throat. These symptoms can last from a few days to a few weeks. Some people have no symptoms at this stage, however. The viral load, or amount of HIV in the blood, at this stage is very high. The second stage of the disease is "chronic HIV infection," during which the virus continues to multiply but at a slower speed than during acute infection. This stage is also called "clinical latency" or "asymptomatic HIV infection," as many people don't feel sick during it. People can remain in this stage of the disease for 10 to 15 years, though some pass through it more quickly. As the virus multiplies, levels of an important type of immune cell — CD4 T lymphocytes — decline. Without treatment, the disease will eventually enter its most advanced stage: AIDS. This can come with a wide range of symptoms, including rapid weight loss; recurring fever; night sweats; extreme tiredness; prolonged swelling of the lymph nodes; diarrhea; sores of the mouth, anus or genitals; and blotches on or under the skin or inside the mouth, nose or eyelids. It can also trigger neurological problems, like memory loss. AIDS raises the risk of severe bacterial infections and cancers, including lymphomas and Kaposi's sarcoma. It can also worsen viral infections, such as hepatitis B and mpox. Without any treatment, people with AIDS typically survive about three years. HIV and AIDS are related, in that AIDS is the most advanced stage of an HIV infection, and therefore, the HIV virus causes both conditions. AIDS can also be called a "stage 3 HIV infection." AIDS is defined in part by a very low CD4 count of fewer than 200 CD4 cells per cubic millimeter (mm3) of blood. Generally speaking, the CD4 counts of healthy teens and adults are around 500 to 1,200 cells/mm3. Anything below 500 cells/mm3 is considered low, and 200 cells/mm3 marks the threshold for an AIDS diagnosis. Doctors also diagnose AIDS by considering a patient's history of "AIDS-defining illnesses." These are medical conditions often seen in people with AIDS because their immune systems can't fight the illnesses off. They include "opportunistic" infections — those caused by germs that wouldn't necessarily harm a person with a well-functioning immune system. Such infections include a fungal infection called extrapulmonary cryptococcosis, recurrent blood infections with Salmonella bacteria, the parasitic infection toxoplasmosis, and lower respiratory infections caused by the herpes simplex virus. The bacterial disease tuberculosis poses a major risk to people with AIDS, and it is currently the leading cause of death for people living with HIV/AIDS worldwide. AIDS-defining illnesses also include cancers such as Kaposi's sarcoma, Burkitt's lymphoma and invasive cervical cancer. Others include HIV encephalopathy, which affects brain function, and HIV wasting syndrome, which causes extreme weight loss and weakness. Complications of AIDS-defining illnesses raise the risk of death, but the degree of risk varies among diseases. At all three stages of the infection, HIV is treated with antiretroviral therapy (ART) — combinations of medications that drive down the amount of HIV in the blood. Different ART drugs work in different ways to keep the amount of virus, or viral load, in check. They are available as daily pills or as shots given periodically throughout the year, depending on the person's treatment plan. It's key for patients to take their medication as prescribed, because missing pills or shots can open the door for the virus to multiply, as well as develop drug resistance, which causes the medication to work less well. ART medications can also interact with other drugs and carry some risk of serious side effects, so patients work with their medical providers to figure out which drug combination is best for them. The goal of ART is "viral suppression," which describes when a person's viral load falls low enough that there are 200 or fewer copies of the virus's genetic material per milliliter (mL) of blood. Historically, tests weren't sensitive enough to detect levels of HIV below that threshold, so doctors called this level "undetectable." Studies also found that people who reach viral suppression can't transmit the virus via sex; have a lower chance of spreading the virus through pregnancy, childbirth or breastfeeding; and likely have a lower chance of spreading it through needle sharing. This is why the slogan "undetectable equals untransmittable," or "U = U," was coined. Nowadays, some tests for HIV are extremely sensitive, so they can detect viral loads significantly below 200 copies/mL. However, experts emphasize that 200 copies/mL is still the critical threshold at which transmission risk becomes extremely low. If a person with HIV/AIDS develops another medical condition, such as an AIDS-defining illness, the individual would receive treatment for that condition in addition to their ART regimen. There is no widespread cure for HIV/AIDS. However, a handful of people have been cured of their HIV infections through stem cell transplants, and a few more are considered "potentially" cured via the same process. Stem cells can develop into different types of cells in the body. In certain cancers that affect blood cells, stem cell transplants can be used to replace the cells lost in the course of cancer treatments such as chemotherapy. Each individual who has been cured of HIV also had one of these cancers, so their doctors searched for stem cell donors who carry a rare gene that makes them resistant to HIV infection. By swapping in cells from an HIV-resistant individual, the procedure essentially locks the virus out of the patient's CD4 cells. There is one exception to this rule: A person known as the "Geneva patient" was potentially cured of HIV after a stem cell transplant, but the donor didn't have this special genetic resistance. It's unclear exactly why the man entered long-term remission from the infection after this procedure, but scientists are investigating. There have also been a couple of cases in which people's own immune systems somehow rallied against the virus and controlled it without treatment; these people are known as "elite controllers." Scientists hope to learn from both the stem cell recipients and from elite controllers to discover cures that could reach far more people with HIV/AIDS. Meanwhile, some researchers are exploring the use of gene-editing tools like CRISPR to cure the infection, while others are investigating the use of drugs and modified immune cells. Antiretroviral therapy (ART) – Combinations of medications that lower the amount of HIV in a person's blood. These drugs, given as pills or shots, prevent the viral infection from progressing to AIDS and dramatically lower a person's risk of complications and of transmitting the virus to others. Pre-exposure prophylaxis (PrEP) – Medicines that people at risk of being exposed to HIV take to prevent the infection. Viral load – The amount of HIV in a person's blood. This is measured in terms of the number of HIV RNA molecules — the virus's genetic material — found in a milliliter of blood. It's an important way to measure how well ART is working. Viral suppression – When a person's viral load falls to 200 copies/mL or lower. Viral suppression is the goal of ART, as it both lowers a person's likelihood of spreading the virus and extends their lifespan by preventing the infection from progressing to AIDS. CD4 T lymphocyte – A type of white blood cell that helps coordinate the actions of other immune cells to fight infections. HIV infects CD4 cells and uses them to multiply while the virus depletes the number of CD4 cells in the body. Image 1 of 4 In the 1980s and 1990s, groups organized "die-ins" to protest the lack of U.S. government attention to the ongoing HIV/AIDS crisis. Die-ins were also conducted to push for support for research to uncover effective treatments and, once treatments were discovered, to demand that those drugs be released to the public. The AIDS Coalition to Unleash Power — known as ACT UP — was a major force behind such protests and remains an active organization today. Image 2 of 4 Kaposi's sarcoma, an example of an AIDS-defining illness, characteristically causes big, purple patches or nodules to appear on the skin and mucous membranes. Image 3 of 4 The public health slogan "U = U," depicted on this sign, refers to the fact that people living with HIV who have undetectable viral loads cannot transmit the virus to others via sex. It stands for "undetectable = untransmittable." Image 4 of 4 The "Berlin patient," pictured here, was the first person cured of HIV via a stem cell transplant. His name was later revealed to be Timothy Ray Brown. Brown went on to launch a foundation under his name that was dedicated to fighting HIV/AIDS. We could end the AIDS epidemic in less than a decade. Here's how. In a 1st, HIV vaccine triggers rare and elusive antibodies in humans Nearly 3 million extra deaths by 2030 could result from HIV funding cuts, study suggests
Yahoo
4 hours ago
- Yahoo
Monster black hole M87 is spinning at 80% of the cosmic speed limit — and pulling in matter even faster
When you buy through links on our articles, Future and its syndication partners may earn a commission. The monster black hole lurking at the center of galaxy M87 is an absolute beast. It is one of the largest in our vicinity and was the ideal first target for the Event Horizon Telescope. Scientists have taken a fresh look at the supermassive black hole using those iconic Event Horizon Telescope images and have now figured out just how fast this monster is spinning and how much material it's devouring. The results are pretty mind-blowing. This black hole, which weighs in at 6.5 billion times the mass of our Sun, is spinning at roughly 80% of the theoretical maximum speed possible in the universe. To put that in perspective, the inner edge of its accretion disk is whipping around at about 14% the speed of light - that's around 42 million meters per second. The team figured this out by studying the "bright spot" in the original black hole images. That asymmetric glow isn't just there for show - it's caused by something called relativistic Doppler beaming. The material on one side of the disk is moving toward us so fast that it appears much brighter than the material moving away from us. By measuring this brightness difference, the scientists could calculate the rotation speed. But here's where it gets really interesting. The researchers also looked at the magnetic field patterns around the black hole, which act like a roadmap for how material spirals inward. They discovered that matter is falling into the black hole at about 70 million meters per second - roughly 23% the speed of light. Using these measurements, they estimated that M87's black hole is consuming somewhere between 0.00004 to 0.4 solar masses worth of material every year. That might sound like a lot, but it's actually pretty modest for such a massive black hole - it's operating well below what scientists call the "Eddington limit," meaning it's in a relatively quiet phase. Related: Scientists just proved that 'monster' black hole M87 is spinning — confirming Einstein's relativity yet again Perhaps most importantly, the energy from all this in-falling material appears to perfectly match the power output of M87's famous jet - that spectacular beam of particles shooting out at near light-speed that extends for thousands of light-years. This supports the idea that these powerful jets are indeed powered by the black hole's feeding process. RELATED STORIES —Time-lapse of 1st black hole ever imaged reveals how matter swirls around it —Astronomers discover black hole ripping a star apart inside a galactic collision. 'It is a peculiar event' —Not 'Little Red Dots' or roaring quasars: James Webb telescope uncovers new kind of 'hidden' black hole never seen before The study represents a major step forward in understanding how supermassive black holes work. While previous estimates of M87's spin ranged anywhere from 0.1 to 0.98, this new method suggests it's definitely on the high end - at least 0.8 and possibly much closer to the theoretical maximum of 0.998. As we gear up for even more powerful telescopes and imaging techniques, M87's black hole will likely remain a cosmic laboratory for testing our understanding of gravity, spacetime, and the most extreme physics in the universe. Each new measurement brings us closer to answering fundamental questions about how these cosmic monsters shape entire galaxies and maybe even how they'll influence the ultimate fate of the cosmos itself. The original version of this article was published on Universe Today.
